Related Experiment Videos

Human recombinant interleukin-2 as an experimental therapeutic

J L Winkelhake¹, S S Gauny

¹Department of Pharmacology, Cetus Corporation, Emeryville, California 94608.

Pharmacological Reviews

|March 1, 1990

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Different mechanisms of radiation-induced loss of heterozygosity in two human lymphoid cell lines from a single donor.

Cancer research·2001

Antigenic peptide binding to MHC class II molecules at increased peptide concentrations.

Molecular immunology·1994

Role of tumor necrosis factor species in the sequence-dependent effects of interleukin-2--tumor necrosis factor immunotherapy in mice: implications for preclinical cytokine testing.

Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy·1994

Human monoclonal antibodies to glycolipid A that exhibit complement species-specific effector functions.

The Journal of infectious diseases·1992

Effect of production method on the systemic clearance rate of a human monoclonal antibody in the rat.

Human antibodies and hybridomas·1991

Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha.

Cancer research·1990

See all related articles